{"name": "Novacta Biosystems",
 "permalink": "novacta-biosystems",
 "crunchbase_url": "http://www.crunchbase.com/company/novacta-biosystems",
 "homepage_url": "http://www.novactabio.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2003,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "mail@novactabio.com",
 "phone_number": "44-(0)-1707-356130",
 "description": "Antibiotics developer",
 "created_at": "Thu Sep 24 22:38:36 UTC 2009",
 "updated_at": "Sat Mar 20 11:04:36 UTC 2010",
 "overview": "\u003Cp\u003ELeveraging the extensive knowledge of GSK\u0026#8217;s Biotransformation and Natural Products scientific team, Novacta Biosystems Ltd was founded in 2003. In the following 5 years, Novacta successfully adopted a dual business model, whereby it developed a biocatalysis and microbial pathway engineering service business, that supported its efforts to build an infectious disease therapeutic pipeline.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       49],
      "assets/images/resized/0006/0775/60775v2-max-150x150.jpg"],
     [[250,
       82],
      "assets/images/resized/0006/0775/60775v2-max-250x250.jpg"],
     [[254,
       84],
      "assets/images/resized/0006/0775/60775v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u00a313.9M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/press-releases/celtic-pharma-holdings-announces-investment-novacta-biosystems-limited-0",
    "source_description": "Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited Read more: http://www.fiercebiotech.com/press-releases/celtic-pharma-holdings-announces-investment-novacta-biosystems-limited-0#ixzz0S4CVeSpv",
    "raised_amount": 13100000.0,
    "raised_currency_code": "GBP",
    "funded_year": 2009,
    "funded_month": 7,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Celtic Pharma",
         "permalink": "celtic-pharma",
         "image":
          {"available_sizes":
            [[[150,
               73],
              "assets/images/resized/0006/1929/61929v2-max-150x150.jpg"],
             [[150,
               73],
              "assets/images/resized/0006/1929/61929v2-max-250x250.jpg"],
             [[150,
               73],
              "assets/images/resized/0006/1929/61929v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 829000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 7,
    "funded_day": 23,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "IQ Capital Partners",
         "permalink": "iq-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               10],
              "assets/images/resized/0002/7276/27276v2-max-150x150.png"],
             [[250,
               16],
              "assets/images/resized/0002/7276/27276v2-max-250x250.png"],
             [[404,
               27],
              "assets/images/resized/0002/7276/27276v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Oxford Technology Management",
         "permalink": "oxford-technology-management",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0007/3351/73351v2-max-150x150.jpg"],
             [[250,
               71],
              "assets/images/resized/0007/3351/73351v2-max-250x250.jpg"],
             [[350,
               100],
              "assets/images/resized/0007/3351/73351v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Esperante Ventures",
         "permalink": "esperante-ventures",
         "image":
          {"available_sizes":
            [[[150,
               90],
              "assets/images/resized/0008/1082/81082v2-max-150x150.png"],
             [[178,
               107],
              "assets/images/resized/0008/1082/81082v2-max-250x250.png"],
             [[178,
               107],
              "assets/images/resized/0008/1082/81082v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "BioPark Hertfordshire",
    "address2": "Broadwater Road",
    "zip_code": "AL7 3AX",
    "city": "Welwyn Garden",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        104],
       "assets/images/resized/0006/3559/63559v1-max-150x150.jpg"],
      [[250,
        173],
       "assets/images/resized/0006/3559/63559v1-max-250x250.jpg"],
      [[450,
        312],
       "assets/images/resized/0006/3559/63559v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}